ArticleFrontiers in medicine2024
A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of
Benjamin D Ehst et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it